Phio Pharmaceuticals Corp Targets $phio

NASDAQ:PHIO   Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp . is a biotechnology company, which engages in the development of immuno-oncology therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Your Intro To Penny Stock Trading Success...

1) Sign Up for our 100% Free Email Newsletter:

2) Follow our Telegram Channel @

3) Join our LIVE CHAT on Discord @

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.